Estados financieros detallados de Avalo Therapeutics, Inc. (AVTX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Avalo Therapeutics, Inc. registró ingresos de $59000 en el último ejercicio fiscal, con un CAGR de 5 años del -61.2%.
Márgenes de los últimos 12 meses: margen bruto -168.6%, margen operativo -1548.4%, margen neto -1700.6%.
Al precio actual de $16.58, AVTX presenta beneficios negativos (P/E no significativo) y un ROE del -58.03%. La capitalización bursátil es de $872M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.2M | $27.8M | $18.3M | $6.8M | $6.7M | $5.4M | $18.1M | $1.9M | $441000 | $59000 |
| Coste de Ventas | $8.2M | $635648 | $7.5M | -$566523 | $300000 | $1.5M | $3.4M | $1.3M | -$366000 | 0 |
| Beneficio Bruto | -$7.1M | $27.2M | $10.8M | $7.3M | $6.4M | $3.9M | $14.6M | $640000 | $807000 | $59000 |
| I+D | $10.2M | $4.4M | $5.8M | $11.8M | $32.2M | $59.8M | $31.3M | $13.8M | $52.1M | $50.1M |
| Generales y Administrativos | $7.1M | $8.9M | $19.2M | $11.6M | $19.8M | $24.7M | $20.7M | $10.3M | $17.2M | $22.9M |
| Gastos Operativos | $17.2M | $13.3M | $29.5M | $23.5M | $6.4M | $86.0M | $52.1M | $28.0M | $69.3M | $73.0M |
| Beneficio Operativo | -$16.1M | $13.9M | -$39.3M | -$16.1M | 0 | -$82.1M | -$37.4M | -$27.4M | -$68.5M | -$72.9M |
| EBITDA | -$16.1M | $14.3M | -$13.1M | -$13.5M | -$45.5M | -$80.5M | -$37.3M | -$23.3M | -$34.8M | -$77.8M |
| Gastos por Intereses | $464181 | $24016 | 0 | 0 | 0 | $2.4M | $4.2M | $3.4M | 0 | 0 |
| Beneficio Antes de Impuestos | -$16.5M | $13.8M | -$40.1M | -$16.0M | -$67.2M | -$84.5M | -$41.6M | -$31.5M | -$35.0M | -$78.1M |
| Impuestos | $364144 | $2.0M | -$33910 | $280316 | -$2.8M | -$196000 | $28000 | $14000 | $114000 | $165000 |
| Beneficio Neto | -$16.5M | $11.9M | -$40.1M | -$16.1M | -$63.5M | -$84.4M | -$41.7M | -$31.5M | -$35.1M | -$78.3M |
| BPA | $-21.93 | $1856.88 | $-3317.28 | $-819.74 | $-2523.77 | $-2330.66 | $-1062.65 | $-113.58 | $-4.32 | $-5.84 |
| BPA Diluido | $-21.93 | $1822.74 | $-3317.28 | $-819.74 | $-2523.77 | $-2330.66 | $-1062.65 | $-113.58 | $-3.26 | $-5.84 |
| Acciones en Circulación (Diluidas) | $3066 | $6512 | $12074 | $19849 | $25511 | $36191 | $39202 | $277727 | $10.8M | $13.4M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.1M | $2.5M | $10.6M | $3.6M | $18.9M | $54.6M | $13.2M | $7.4M | $134.5M | $15.9M |
| Inversiones a Corto | 0 | 0 | 0 | $7.6M | 0 | 0 | 0 | 0 | 0 | $82.5M |
| Cuentas por Cobrar | $132472 | $2.9M | $6.1M | $5.2M | $4.4M | $4.8M | $1.9M | $136000 | $611000 | 0 |
| Inventario | $11000 | $382153 | $1.1M | $21334 | $3000 | $38000 | $20000 | 0 | 0 | 0 |
| Activos Corrientes | $5.7M | $11.0M | $21.9M | $17.7M | $26.0M | $61.8M | $16.4M | $8.4M | $138.9M | $105.3M |
| Inmovilizado Material | $43000 | $44612 | $586512 | $1.4M | $1.6M | $2.7M | $2.4M | $2.0M | $1.2M | $460000 |
| Fondo de Comercio | 0 | $14.3M | $16.4M | $14.4M | $14.4M | $14.4M | $14.4M | $10.5M | $10.5M | $10.5M |
| Activos Intangibles | 0 | $17.7M | $31.2M | $2.4M | $1.6M | $38000 | 0 | 0 | 0 | 0 |
| Activos Totales | $5.8M | $43.1M | $70.3M | $36.1M | $43.8M | $80.2M | $33.4M | $21.0M | $150.7M | $116.5M |
| Cuentas por Pagar | $1.0M | $1.3M | $1.4M | $2.1M | $2.6M | $3.4M | $2.9M | $446000 | $283000 | $137000 |
| Deuda a Corto | $2.4M | 0 | 0 | 0 | 0 | 0 | $5.9M | 0 | 0 | 0 |
| Pasivos Corrientes | $4.3M | $11.4M | $26.2M | $12.2M | $15.2M | $19.9M | $22.1M | $4.6M | $7.0M | $12.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $32.8M | $13.5M | 0 | 0 | $2.0M |
| Pasivos Totales | $5.6M | $15.3M | $49.3M | $15.1M | $19.2M | $57.1M | $44.3M | $13.7M | $17.7M | $33.4M |
| Reservas | -$70.0M | -$58.2M | -$98.2M | -$114.3M | -$177.8M | -$262.2M | -$303.8M | -$335.1M | -$370.3M | -$448.5M |
| Patrimonio Neto | $207000 | $27.9M | $20.9M | $21.0M | $24.6M | $23.1M | -$10.9M | $7.3M | $133.0M | $83.0M |
| Deuda Total | $2.4M | 0 | $15.4M | $155815 | $426000 | $33.3M | $19.9M | $537000 | $568000 | $2.4M |
| Deuda Neta | -$2.8M | -$2.5M | $4.7M | -$11.1M | -$18.5M | -$21.3M | $6.8M | -$6.9M | -$134.0M | -$95.9M |
| Capital Circulante | $1.4M | -$415070 | -$4.3M | $5.6M | $10.8M | $42.0M | -$5.7M | $3.8M | $131.9M | $92.3M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$16.5M | $11.9M | -$40.1M | -$16.1M | -$63.5M | -$84.4M | -$41.7M | -$31.5M | -$35.1M | -$78.3M |
| Amortizaciones | $26856 | $425476 | $4.6M | $3.9M | $1.8M | $1.7M | $166000 | $158000 | $169000 | $344000 |
| Compensación en Acciones | $1.7M | $1.2M | $2.4M | $2.5M | $6.8M | $8.2M | $7.6M | $3.5M | $5.9M | $13.6M |
| Cambio en Capital Circulante | $87073 | -$466751 | $8.7M | -$2.0M | -$4.4M | $2.8M | -$60000 | -$9.2M | -$4.7M | $3.8M |
| Flujo de Caja Operativo | -$14.6M | $12.5M | -$3.1M | -$19.1M | -$40.5M | -$70.9M | -$26.8M | -$30.7M | -$49.1M | -$51.5M |
| Inversiones (CapEx) | -$34883 | -$23325 | -$564415 | -$262013 | -$63000 | -$113000 | -$95000 | -$158000 | 0 | 0 |
| Adquisiciones | 0 | -$18.9M | $1.4M | 0 | $11.2M | 0 | 0 | 0 | $356000 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.6M | $12.5M | -$3.7M | -$19.4M | -$40.6M | -$71.0M | -$26.8M | -$30.8M | -$49.1M | -$51.5M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +2312.2% | -34.1% | -63.2% | -0.8% | -19.4% | +234.4% | -89.3% | -77.1% | -86.6% | |
| Crecimiento Beneficio Neto (anual) | +172.1% | -437.4% | +59.9% | -295.1% | -32.9% | +50.6% | +24.3% | -11.4% | -122.8% | |
| Crecimiento BPA (anual) | +8567.3% | -278.6% | +75.3% | -207.9% | +7.7% | +54.4% | +89.3% | +96.2% | -35.2% | |
| Cambio en Acciones (anual) | +112.4% | +85.4% | +64.4% | +28.5% | +41.9% | +8.3% | +608.5% | +3783.0% | +24.3% | |
| Crecimiento FCF (anual) | +185.5% | -129.5% | -425.3% | -109.3% | -74.9% | +62.2% | -14.9% | -59.1% | -4.9% | |
| Margen Bruto | -614.6% | 97.7% | 59.2% | 108.4% | 95.5% | 72.4% | 81.0% | 33.3% | 183.0% | 100.0% |
| Margen Operativo | -1394.6% | 49.9% | -214.5% | -239.1% | 0.0% | -1521.6% | -207.4% | -1421.6% | -15535.6% | -123601.7% |
| Margen EBITDA | -1392.3% | 51.6% | -71.3% | -200.1% | -678.5% | -1491.2% | -206.6% | -1210.3% | -7901.6% | -131779.7% |
| Margen Neto | -1428.5% | 42.7% | -218.5% | -238.1% | -947.9% | -1563.1% | -230.8% | -1639.5% | -7965.8% | -132642.4% |
| Margen FCF | -1267.0% | 44.9% | -20.1% | -287.3% | -606.1% | -1315.4% | -148.7% | -1602.8% | -11123.8% | -87216.9% |
| Tasa Impositiva Efectiva | -2.2% | 14.2% | 0.1% | -1.8% | 4.2% | 0.2% | -0.1% | -0.0% | -0.3% | -0.2% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-4764.35 | $1918.91 | $-305.82 | $-977.20 | $-1591.55 | $-1961.95 | $-684.81 | $-111.04 | $-4.55 | $-3.84 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $3066 | $6392 | $12074 | $19849 | $25511 | $36191 | $39202 | $277727 | $8.1M | $13.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -58.03% |
| Rentabilidad sobre capital invertido | -19.44% |
| Rentabilidad sobre activos | -20.44% |
| Margen bruto | -16861.02% |
| Margen operativo | -154844.07% |
| Margen neto | -170055.93% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 19.31 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -2.13 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -115.57 | 4.96 | -2.80 | -18.94 | -3.01 | -2.10 | -1.14 | -0.08 | -1.72 | -3.11 |
| P/VC | 37.54 | 2.11 | 5.37 | 14.68 | 7.90 | 7.68 | -4.34 | 0.35 | 0.45 | 2.93 |
| P/V | 6.74 | 2.12 | 6.13 | 45.65 | 28.95 | 32.83 | 2.63 | 1.31 | 136.95 | 4125.96 |
| Margen Bruto | -614.6% | 97.7% | 59.2% | 108.4% | 95.5% | 72.4% | 81.0% | 33.3% | 183.0% | 100.0% |
| Margen Operativo | -1394.6% | 49.9% | -214.5% | -239.1% | 0.0% | -1521.6% | -207.4% | -1421.6% | -15535.6% | -123601.7% |
| Margen Neto | -1428.5% | 42.7% | -218.5% | -238.1% | -947.9% | -1563.1% | -230.8% | -1639.5% | -7965.8% | -132642.4% |
Empresas relacionadas: AARD · BDTX · CHRS · CRBU · ENTA · EPRX · IVA
Explorar sector: Healthcare · Biotechnology
Más secciones de AVTX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones